Cyclerion Therapeutics
CYCN
CYCN
17 hedge funds and large institutions have $249K invested in Cyclerion Therapeutics in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
34% less capital invested
Capital invested by funds: $376K → $249K (-$127K)
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$58.7K | |
| 2 | +$26K | |
| 3 | +$14.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.29K |
| 5 |
CIAM
Caitong International Asset Management
Hong Kong
|
+$6 |
Top Sellers
| 1 | -$147K | |
| 2 | -$52.8K | |
| 3 | -$12.7K | |
| 4 |
Citigroup
New York
|
-$11.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.01K |
